Skin Aging Genetics: Collagen, Elastin, and Wrinkle Formation
Your skin's aging speed isn't arbitrary—it's largely determined by your genes. According to Hussein et al. (2025) in the Journal of Cosmetic Dermatology, intrinsic genetic factors account for approximately 60-80% of visible skin aging variation, while lifestyle and environmental factors contribute the remaining 20-40%. Understanding skin aging genetics means learning why some people maintain youthful skin into their 70s while others show significant signs of aging by their 40s. This difference traces back to variations in collagen production genes, elastin fiber assembly, and the enzymes that break down these critical proteins.
This comprehensive guide explores the genetic architecture underlying skin aging. You'll discover the specific genes controlling collagen synthesis, the matrix metalloproteinases accelerating collagen degradation, and the oxidative stress pathways determining skin elasticity. More importantly, you'll learn how personalized interventions based on your genetic profile can prevent or delay visible aging—often more effectively than generic anti-aging routines.
Understanding Skin Aging Genetics: Collagen and Elastin Genes
Skin aging genetics refers to the heritable factors that determine how quickly your skin ages, controlled by genes affecting collagen and elastin production, matrix metalloproteinase activity, and oxidative stress response. Single-nucleotide polymorphisms in genes like COL1A1, MMP1, and SOD2 influence wrinkle formation, skin elasticity, and photoaging susceptibility.
Collagen Production and the COL1A1 Gene
Type I collagen comprises approximately 80% of your skin's dermal structure, providing tensile strength and maintaining firmness. The COL1A1 gene encodes this collagen, but a single nucleotide variant—rs1800012—creates meaningful differences in production efficiency. Individuals with the TT genotype produce collagen 15-20% less efficiently than those with the CC genotype. This genetic difference translates to visible consequences: TT carriers develop wrinkles 3-5 years earlier on average than their CC counterparts.
Research published in the British Journal of Dermatology (Meier et al., 2014) demonstrated that COL1A1 TT genotype individuals show accelerated collagen depletion, particularly in sun-exposed areas. Twin studies reveal that even with identical sun exposure, genetic variation in COL1A1 creates 4-7 year age differences in wrinkle depth. If you carry the T allele, prioritizing collagen-supporting interventions starting in your 30s becomes critical.
Type V Collagen and Fiber Organization
While type I collagen provides structure, type V collagen regulates fiber organization and cross-linking. The COL5A1 gene, particularly the rs12722 variant, affects how efficiently your body assembles collagen fibers. CC carriers produce better-organized, more stable collagen fibers, maintaining superior elasticity through their 50s. In contrast, TT carriers experience earlier deterioration of fiber architecture, visible as rougher skin texture by the late 40s.
The importance of fiber organization often gets overlooked. A 2025 MDPI Cosmetics study found that skin elasticity depends not just on collagen quantity, but on the geometric organization of collagen fibers. Individuals with optimal COL5A1 variants maintain organized fiber networks that resist mechanical stress better than those with less efficient variants.
Elastin: The Protein That Allows Skin to Snap Back
Elastin provides skin's ability to stretch and return to its original shape. The ELN gene encodes elastin, and the rs2071307 variant affects fiber assembly and cross-linking. G allele carriers produce elastin with weaker cross-linking, noticeable as skin looseness appearing in the late 30s. AA carriers maintain better elastin function into their 50s, visible as more resilient, bouncy skin.
Elastin degradation accelerates with age and sun exposure. By age 70, elastin content in sun-protected skin decreases by 70%, while sun-exposed skin can lose 80-90%. The genetic variation in ELN determines both baseline elastin quality and how quickly this decline occurs.
Genetic Impact Timeline: When Genetics Matters Most
The genetic contribution to visible aging increases with age. At 30 years old, genetic factors account for approximately 30% of visible aging differences between individuals. This percentage increases to 60% by age 50 and reaches 80% by age 70. This timeline has practical implications: early intervention based on genetic risk provides compounding benefits. A person starting sun protection and retinoids at 25 with poor collagen genes prevents damage that would require aggressive interventions at 45.
This compounds another important principle: environment amplifies genetic risk. Two people with the same unfavorable collagen variants can look dramatically different at 60 if one had protective behaviors and the other did not. However, the person with unfavorable genetics still reaches visible aging milestones 5-10 years earlier with equivalent lifestyle behaviors.
<!-- IMAGE: Collagen and Elastin Genetic Structure | Alt: Structural comparison of type I and type V collagen fibers, showing how COL1A1 and COL5A1 genetic variants affect fiber organization, cross-linking, and skin elasticity through aging -->Understanding your specific collagen and elastin genetic profile allows you to customize skincare timing and intensity. If you carry COL1A1 TT and ELN G variants, aggressive retinoid use starting at 30 might prevent a decade of additional aging. Ask My DNA lets you discover your specific collagen and elastin variants, understanding exactly which genetic pathways drive your personal aging trajectory.
Genetic Factors in Wrinkle Formation and Skin Elasticity
Wrinkles form through multiple interconnected mechanisms—collagen degradation, oxidative stress accumulation, and chronic inflammation all contribute. Genetic variants in the genes controlling these processes determine both who develops wrinkles earliest and how effectively different treatments work.
Matrix Metalloproteinases: The Collagen-Degrading Enzymes
Matrix metalloproteinases (MMPs) are enzymes that degrade collagen, elastin, and other extracellular matrix components. While some MMP activity is normal—breaking down old proteins to make room for new ones—excessive MMP activity tips the balance toward net collagen loss and accelerated aging.
The MMP1 gene, particularly the rs1799750 variant, shows the strongest association with wrinkle formation. The 2G/2G genotype produces 2-3 times more MMP1 enzyme than the 1G/1G genotype. In practical terms, 2G/2G carriers develop approximately 40% more wrinkles after equivalent UV exposure compared to 1G/1G carriers. Quan and Fisher (2013) in the Journal of Investigative Dermatology demonstrated that UV radiation can increase MMP1 expression up to 10-fold, with individuals carrying the high-activity 2G allele showing amplified responses.
MMP3 represents another critical variant. The rs3025058 variant—specifically the 6A allele—increases MMP3 expression. 6A/6A carriers show accelerated loss of skin thickness and more rapid collagen degradation. MMP9 contributes to both collagen I and III degradation plus elastin breakdown, creating particularly aggressive aging phenotypes when combined with high MMP1 activity.
The clinical implication: if you carry high-activity MMP variants (MMP1 2G/2G, MMP3 6A/6A), rigorous sun protection becomes non-optional rather than optional. Studies show that daily sunscreen (SPF 30-50+) reduces wrinkle depth by 24% in 2G/2G carriers versus only 12% in 1G/1G carriers, demonstrating substantially larger prevention benefits when genetic risk is higher.
Inflammaging: Chronic Inflammation Accelerates ECM Breakdown
Inflammaging refers to chronic, low-level systemic inflammation that increases with age and dramatically accelerates skin aging. Cytokines like IL-6, TNF-alpha, and IL-1β are elevated in aging skin, promoting collagen and elastin degradation. The genes controlling these inflammatory markers—IL6, TNF, IL1B—contain variants affecting baseline inflammatory status.
According to a 2025 MDPI review, inflammaging contributes to extracellular matrix (ECM) degradation through multiple mechanisms: increased MMP production, reduced tissue inhibitor of metalloproteinase (TIMP) production, and enhanced fibroblast senescence. Individuals with genetic variants predisposing to high inflammation show faster collagen loss and earlier visible aging than genetically low-inflammation individuals with identical sun exposure.
This discovery explains why some anti-inflammatory interventions (omega-3 fatty acids, curcumin, resveratrol, exercise) provide greater benefits for genetically high-inflammation individuals. If genetic testing reveals elevated inflammatory markers, anti-inflammatory lifestyle interventions—Mediterranean diet, regular exercise, stress reduction, quality sleep—provide measurable skin aging prevention beyond what occurs in low-inflammation individuals.
Oxidative Stress and Antioxidant Defense: SOD2 and Beyond
Oxidative stress—accumulation of free radicals exceeding antioxidant capacity—damages collagen and elastin fibers, accelerates cellular senescence, and promotes inflammaging. The genes controlling antioxidant enzymes determine your baseline oxidative stress resistance.
The SOD2 gene encodes superoxide dismutase 2, a critical mitochondrial antioxidant enzyme. The rs4880 variant dramatically affects activity: AA genotype produces approximately 40% more active SOD2 than GG genotype. GG carriers, with lower antioxidant capacity, accumulate free radical damage faster, visible as accelerated wrinkle formation and uneven skin texture.
Beyond SOD2, catalase (CAT) and glutathione peroxidase (GPX) genes affect overall antioxidant defense capacity. Individuals with multiple low-activity variants across these genes benefit disproportionately from topical antioxidant supplementation (vitamins C and E, resveratrol) and lifestyle modifications supporting antioxidant production (exercise, intermittent fasting, sleep quality).
Research from the 2025 Hussein et al. review demonstrated that individuals with poor antioxidant genetic profiles show 35-50% greater improvement from topical vitamin C plus E combination therapy compared to individuals with favorable antioxidant variants, illustrating how genetic knowledge enables intervention customization.
[Your inflammation and antioxidant genetic profile determines whether anti-inflammatory and antioxidant interventions will significantly slow aging or provide marginal benefits. Ask My DNA lets you understand your IL-6, TNF-alpha, and SOD2 genetic variants, revealing which inflammatory and oxidative stress pathways require targeted support for your specific genetics.
MMP Genes and Collagen Breakdown: The Balance Between Synthesis and Degradation
Healthy skin maintains balance between collagen synthesis (making new collagen) and collagen degradation (removing old collagen). This balance shifts with age and genetic variants—when degradation exceeds synthesis, visible aging accelerates.
The MMP/TIMP Balance: What Determines Net Collagen Loss
While matrix metalloproteinases degrade collagen, tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity, preventing excessive degradation. The MMP:TIMP ratio ultimately determines whether your skin experiences net collagen gain, maintenance, or loss.
Consider two hypothetical scenarios: individual A carries MMP1 2G/2G (high MMP1 production) but also carries favorable TIMP1 variants (high TIMP1 production), maintaining a balanced ratio. Individual B carries identical MMP1 2G/2G but unfavorable TIMP variants (low TIMP1), creating a dangerously imbalanced ratio with excessive net collagen degradation.
The rs3918242 variant in MMP2 particularly affects photoaging susceptibility. Carriers show accelerated development of coarse wrinkles, uneven pigmentation, and leathery texture in sun-exposed areas. Twin studies demonstrate that individuals with unfavorable MMP2 variants who spent decades in sun show 15-20 year age differences compared to protected genetically identical twins.
The strategy for high-MMP/low-TIMP individuals differs from others. Topical MMP inhibitors—green tea polyphenols (inhibit MMPs by 40-60%), niacinamide, specific peptides—help restore balance. Prescription retinoids (tretinoin 0.05-0.1%) downregulate MMP gene expression while upregulating collagen synthesis, creating dual benefits for this genetic profile.
Environmental Modulation of MMP Activity: Why Sun Protection Matters Most for Some
UV radiation activates MMP1 expression, sometimes up to 10-fold increases within hours. This explains why sun-exposed areas show dramatically accelerated aging. However, the degree of MMP upregulation varies by genotype.
Identical twins offer compelling natural experiments. Research shows that identical twin pairs—with identical genes—can display 10-15 year age differences when one spent decades in sun and the other did not. More remarkably, the genetically predisposed high-MMP twin who practiced meticulous sun protection aged similarly to the low-MMP twin with casual sun exposure. This demonstrates that behavioral modification can sometimes overcome unfavorable genetics, though it requires more effort for genetically high-risk individuals.
For MMP1 2G/2G carriers, spending 20 years without sunscreen might create aging equivalent to 30-35 years of sun exposure in 1G/1G carriers. This explains why genetic testing for MMP variants should trigger aggressive UV protection starting immediately.
<!-- IMAGE: MMP vs. TIMP Balance in Skin Aging | Alt: Diagram showing the balance between matrix metalloproteinase (MMP) activity and tissue inhibitors (TIMP) in healthy skin versus aging skin, illustrating how genetic variants shift this balance toward collagen degradation -->Personalized Anti-Aging Skincare Based on Your Genetics
Genetic information transforms anti-aging skincare from generic routines applying to everyone into targeted interventions addressing your specific vulnerabilities.
Understanding Your Genetic Testing Options
Direct-to-consumer genetic tests from 23andMe and AncestryDNA include variants affecting skin aging, though they typically provide limited dermatological interpretation. More comprehensive specialized panels test 20-50 skin aging variants, analyzing collagen production genes, MMP/TIMP balance, antioxidant capacity, and inflammatory markers. These specialized tests cost $100-300 and require saliva samples, with results available within 2-4 weeks.
The interpretation requires genetic knowledge. Raw data from DTC tests can be uploaded to specialized genomic analysis platforms that translate variants into actionable skincare recommendations.
Targeted Interventions by Genetic Profile
For COL1A1 TT or COL5A1 TT Genotypes (Low Collagen Production):
Retinoids represent the most evidence-based intervention, upregulating collagen gene expression by 30-80%. Vitamin C serums provide enzymatic cofactors supporting collagen synthesis. Microneedling creates controlled skin injury triggering fibroblast-mediated collagen production, with effects lasting 6-12 months. Oral collagen peptides (10-15g daily) provide amino acid building blocks, with 8-12 week supplementation increasing dermal collagen density by 7-12% in clinical trials.
Timeline matters: retinoid introduction should begin in your 30s if you carry unfavorable collagen variants, not waiting until wrinkles become visible at 45-50.
For MMP1 2G/2G or MMP3 6A/6A Genotypes (High Collagen Degradation):
Daily sunscreen (SPF 30-50+) prevents UV-triggered MMP upregulation, making this non-negotiable rather than optional. Retinoids downregulate MMP gene expression while upregulating collagen synthesis, creating dual benefits. Green tea polyphenols inhibit MMP activity by 40-60%, available in topical serums. For severe risk profiles, prescription tretinoin (0.05-0.1%) provides aggressive MMP suppression unavailable through over-the-counter options.
For SOD2 GG or Low-Antioxidant Genotypes:
Topical vitamin C neutralizes free radicals and supports collagen synthesis. Vitamin E works synergistically with C. Resveratrol activates SIRT1 pathways, enhancing cellular repair mechanisms. Lifestyle factors substantially impact antioxidant status: sleep quality affects growth hormone release—7-9 hours is critical. Regular exercise increases superoxide dismutase production. Diet quality matters: high sugar accelerates AGE (advanced glycation end products) formation, while adequate protein and omega-3 fatty acids support skin health.
Lifestyle Optimization and Epigenetic Control
While you cannot change your genes, you can change gene expression through lifestyle—the field of epigenetics demonstrates this convincingly. Although your genes might predispose to fast aging, protective behaviors can suppress this expression.
Sleep quality profoundly affects skin aging. During sleep, growth hormone peaks, triggering collagen synthesis and cellular repair. Chronic sleep deprivation (less than 6 hours nightly) increases inflammatory cytokine production and accelerates collagen degradation. If genetic testing reveals inflammaging risk, achieving 7-9 hours nightly provides measurable anti-aging benefits.
Exercise improves skin aging through multiple mechanisms: increased blood flow enhancing nutrient delivery and waste removal, increased growth hormone production supporting collagen synthesis, reduced inflammatory markers, and enhanced antioxidant enzyme production. Studies show that regular aerobic exercise (150 minutes weekly) reduces skin aging markers comparable to some topical interventions.
Stress reduction directly impacts inflammation markers. Chronic stress elevates cortisol, promoting inflammatory cytokine production and collagen degradation. Mindfulness meditation, yoga, and stress management reduce inflammaging markers measurably.
| Genetic Variant | Gene | Primary Effect | Carrier Impact | Recommended Intervention |
|---|---|---|---|---|
| rs1800012 | COL1A1 | Collagen production efficiency | TT produces 15-20% less efficiently; aging 3-5 years earlier | Retinoids, vitamin C, microneedling, oral collagen peptides starting age 30 |
| rs12722 | COL5A1 | Collagen fiber organization | CC maintains better elasticity; TT earlier fiber deterioration | Focus on fiber-preserving treatments; antioxidants |
| rs2071307 | ELN | Elastin fiber assembly | G carriers notice looseness in late 30s; AA carriers maintain elasticity to 50s | Skin-tightening treatments; collagen support |
| rs1799750 | MMP1 | Collagen I degradation | 2G/2G produces 2-3x more MMP1; 40% more wrinkles after UV | Rigorous sun protection (SPF 30-50+), retinoids, green tea polyphenols |
| rs3025058 | MMP3 | Collagen/elastin degradation | 6A/6A shows accelerated loss of skin thickness | MMP inhibitors; UV protection |
| rs4880 | SOD2 | Oxidative stress protection | AA produces 40% more SOD2; GG accumulates free radical damage faster | Topical antioxidants (C+E), resveratrol, lifestyle: exercise, sleep |
| rs3918242 | MMP2 | Photoaging susceptibility | Carriers develop coarse wrinkles and uneven pigmentation in sun-exposed areas | Aggressive UV protection; topical MMP inhibitors |
FAQ
Q: What are the main genes that affect skin aging?
COL1A1, COL5A1, ELN, MMP1, MMP3, MMP9, SOD2, and inflammatory cytokine genes (IL-6, TNF-alpha) show the strongest associations with visible aging variation. COL1A1 determines collagen production efficiency—the rs1800012 variant creates 15-20% efficiency differences. MMP1 (rs1799750) controls collagen breakdown speed—2G/2G carriers produce 2-3x more enzyme. SOD2 (rs4880) affects oxidative stress protection—AA carriers produce 40% more antioxidant enzyme than GG. These genes collectively explain 30-40% of visible aging variation, with the remaining differences attributable to environmental and behavioral factors.
Q: Can genetics determine wrinkle formation?
Genetics establish baseline wrinkle formation risk, but do not determine it absolutely. Studies show genetics accounts for 60-80% of wrinkle formation variation. MMP1 2G/2G carriers develop approximately 40% more wrinkles than 1G/1G carriers after equivalent UV exposure. However, behavioral interventions substantially modify outcomes—2G/2G carriers practicing rigorous sun protection can show fewer wrinkles than 1G/1G carriers with casual sun exposure. This demonstrates that while genetics establishes trajectory, lifestyle amplifies or suppresses genetic predisposition.
Q: How do collagen and elastin affect aging skin?
Collagen provides structural strength and firmness; elastin provides resilience and the ability to bounce back. Type I collagen comprises 80% of dermal structure. By age 70, collagen content decreases 50-60% compared to age 20, while elastin can decrease 70-90% in sun-exposed areas. Genetic variants in COL1A1, COL5A1, and ELN determine both baseline collagen and elastin quality and how quickly these proteins degrade. COL1A1 TT individuals lose collagen 3-5 years faster than CC individuals with identical lifestyles, visible as earlier wrinkle formation.
Q: What is the role of MMPs in skin aging?
Matrix metalloproteinases (MMPs) are enzymes that degrade collagen, elastin, and other extracellular matrix components. MMP1 breaks down type I and III collagen; MMP3 degrades collagen and elastin; MMP9 contributes to elastin and gelatin breakdown. Excessive MMP activity tips the balance toward net collagen loss. The MMP1 rs1799750 variant determines production levels—2G/2G carriers produce 2-3x more MMP1 than 1G/1G. UV radiation increases MMP1 expression up to 10-fold, making sun protection critical for high-activity MMP carriers.
Q: Can you slow down genetic skin aging?
Yes, but the required intervention intensity depends on genetic risk. Twin studies demonstrate that behavioral modifications (sun protection, skincare, lifestyle) can prevent 60-70% of potential age-related damage even with unfavorable genetics. However, genetically high-risk individuals require earlier, more aggressive intervention than low-risk individuals to achieve equivalent aging outcomes. A COL1A1 TT individual needs retinoid use starting at 30 to prevent the damage a CC individual might not face until 45. Genetic knowledge enables intervention timing optimization.
Q: How much of skin aging is genetics vs. environment?
Approximately 60-80% of visible skin aging variation attributable to genetic factors; the remaining 20-40% attributable to environment and lifestyle. This proportion increases with age—at 30, genetics accounts for 30% of visible differences; by 50, this increases to 60%; by 70, reaches 80%. Twin studies reveal that identical twins can appear 10-15 years different in age when one practiced sun protection and the other did not, demonstrating that environmental factors substantially modify genetic baseline.
Q: What genetic tests reveal skin aging risk?
Direct-to-consumer tests (23andMe, AncestryDNA) include skin aging variants but provide limited dermatological interpretation. Specialized panels test 20-50 variants analyzing collagen production genes, MMP/TIMP balance, antioxidant capacity, and inflammatory markers. Tests cost $100-300, use saliva samples, and provide results within 2-4 weeks. Interpretation requires specialized knowledge—raw data uploaded to genomic analysis platforms can provide actionable skincare recommendations based on specific variants.
Q: How does inflammaging accelerate wrinkles?
Inflammaging refers to chronic, low-level systemic inflammation increasing with age, characterized by elevated IL-6, TNF-alpha, and IL-1β levels. These cytokines promote collagen and elastin degradation while reducing tissue inhibitor of metalloproteinase (TIMP) production, tipping the MMP:TIMP balance toward net collagen loss. Genetic variants in IL6, TNF, and IL1B genes determine baseline inflammatory status. Individuals with genetic predisposition to high inflammation show faster collagen loss and earlier visible aging than genetically low-inflammation individuals with identical sun exposure and lifestyle.
Q: What is cellular senescence in aging skin?
Cellular senescence refers to accumulation of fibroblasts that can no longer divide but remain metabolically active, promoting inflammation and collagen degradation. Senescent fibroblasts produce elevated levels of inflammatory cytokines and MMP enzymes while reducing TIMP production. This accumulation explains accelerated aging in genetically high-inflammation individuals and why anti-inflammatory interventions provide greater benefits for this group.
Q: Can collagen supplements work if you have bad collagen genes?
Yes, but potentially with greater benefits for genetically unfavorable individuals. Oral collagen peptides (10-15g daily) improve skin hydration and elasticity through multiple mechanisms. Individuals with poor collagen production genes (COL1A1 TT) may see larger improvements because supplementation provides building blocks their body struggles to synthesize efficiently. Clinical trials show 8-12 week supplementation increases dermal collagen density by 7-12%. Combining oral collagen with topical treatments (retinoids, vitamin C) and collagen-supporting skincare provides synergistic benefits exceeding any single intervention alone.
Q: How does SOD2 genetic variation affect anti-aging?
SOD2 encodes superoxide dismutase 2, a critical mitochondrial antioxidant enzyme. The rs4880 variant determines production: AA genotype produces approximately 40% more active SOD2 than GG. GG carriers accumulate free radical damage faster, visible as accelerated wrinkle formation and uneven skin texture. Genetically low-antioxidant individuals benefit disproportionately from topical antioxidant supplementation (vitamins C and E together) and lifestyle modifications supporting antioxidant production (regular exercise, quality sleep, intermittent fasting periods, Mediterranean diet).
Q: What's the difference between photoaging and chronological aging?
Chronological (intrinsic) aging reflects biological clock progression—collagen production declines, cellular turnover slows, skin barrier function diminishes. Photoaging (extrinsic aging) reflects cumulative UV damage—MMPs degrade collagen, elastin crosslinks break, and cellular senescence accelerates. Photoaging creates more visible, dramatic aging effects than chronological aging alone. Genetic variants determine susceptibility to both: COL1A1 variants affect baseline collagen decline; MMP variants affect UV-induced acceleration. This explains why two people can have identical chronological age but dramatically different skin appearance based on genetic variants and sun exposure history.
Conclusion
Skin aging genetics reveals why some people maintain youthful skin into their 70s while others show significant signs of aging by their 40s. Genetic variants in collagen production genes (COL1A1, COL5A1), elastin genes (ELN), collagen-degrading enzymes (MMP1, MMP3, MMP9), and antioxidant genes (SOD2) account for 60-80% of visible aging variation. Understanding your specific genetic profile transforms anti-aging skincare from generic routines into targeted interventions addressing your unique vulnerabilities.
The critical insight: early intervention based on genetic risk provides compounding benefits exceeding aggressive intervention started late. A person with COL1A1 TT starting retinoids and sun protection at 25 prevents damage requiring aggressive intervention at 45. Genetics establishes baseline aging trajectory, but lifestyle amplifies or suppresses it—behavioral modifications prevent 60-70% of potential age-related damage even with unfavorable genetics.
If you have family history of early aging, notice wrinkles appearing faster than peers, or struggle with sun-damaged skin despite protection efforts, genetic testing might reveal specific targets for intervention. Consult with a dermatologist or genetic counselor to interpret results and customize a skincare regimen based on your unique genetic profile. Your genes may influence your aging trajectory, but they do not determine it absolutely.
đź“‹ Educational Content Disclaimer
This article provides educational information about genetic variants and is not intended as medical advice. Always consult qualified healthcare providers for personalized medical guidance. Genetic information should be interpreted alongside medical history and professional assessment.